{
    "clinical_study": {
        "@rank": "77241", 
        "arm_group": {
            "arm_group_label": "A1c, Self-collection, Blood sample", 
            "arm_group_type": "Experimental", 
            "description": "Can a lay-persons safely and effectively self-collect a capillary blood sample of sufficient adequacy for A1c (\"HbA1c\") testing in a clinical laboratory"
        }, 
        "brief_summary": {
            "textblock": "This is a study to evaluate the safety and effectiveness of Micro-Serum/Micro-Blood (finger\n      Stick) Specimen Collection as compared to samples obtained by standard venipuncture (blood\n      taken from the arm vein)."
        }, 
        "brief_title": "Comparison Study of Lay Person Finger Stick Versus Blood Draw", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes", 
        "detailed_description": {
            "textblock": "This is a study to evaluate the safety and effectiveness of Micro-Serum/Micro-Blood (finger\n      Stick) Specimen Collection as compared to samples obtained by standard venipuncture (blood\n      taken from the arm vein).  The information and data obtained will be used to finish\n      development of a convenience kit that allows doctors to provide their patients a method to\n      have their blood tested for clinical laboratory tests in the convenience of their home\n      without having to visit the doctor's office or clinic."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Ability to understand and follow verbal and written instructions in English\n\n          2. Demonstrate a willingness to participate by providing a written informed consent\n\n          3. Aged between 18 to 80 years of age with no obvious signs of illness (e.g. fever,\n             vomiting)\n\n          4. Diabetics who were diagnosed 6 months ago or longer are preferred.  However,\n             non-diabetics will be accepted into the study.\n\n        Exclusion Criteria:\n\n          1. Withdrawn informed consent\n\n          2. Mental or physical impairment which would preclude participation\n\n          3. Any condition which, in the opinion of the Principle Investigator or site or study\n             coordinator, makes the participant unsuitable for this study. This includes but is\n             not limited to any mental or physical impairment, which would preclude provision of\n             adequate and knowledgeable consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913145", 
            "org_study_id": "040412"
        }, 
        "intervention": {
            "arm_group_label": "A1c, Self-collection, Blood sample", 
            "description": "This is a study to evaluate the safety and effectiveness of Micro-Serum/Micro-Blood (finger Stick) Specimen Collection as compared to samples obtained by standard venipuncture (blood taken from the arm vein).", 
            "intervention_name": "A1c, Self-collection, Blood sample", 
            "intervention_type": "Device", 
            "other_name": "HomeAccess A1c Kit"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 18, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Mateo", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94401"
                    }, 
                    "name": "Mills-Peninsula Health Services"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40213"
                    }, 
                    "name": "L-MARC"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Usability and HbA1c Method Comparison Study Using Lay Person Micro-Blood Specimens", 
        "overall_official": [
            {
                "affiliation": "Mills-Peninsula Health Services Dorothy L. and James E. Frank Diabetes Research Institute 100 South San Mateo Drive San Mateo, California 94401", 
                "last_name": "David Klonoff, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "L-MARC, 3288 Illinois Ave., Louisville, KY", 
                "last_name": "Harold E. Bayes, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To establish that when using capillary blood collected in the Home Access Collection Cassette, lay-users can obtain HbA1c results equivalent to results from professionally-collected samples", 
            "measure": "Usability and HbA1c Method Comparison Study Using Lay-Person Micro-Blood Specimens", 
            "safety_issue": "No", 
            "time_frame": "Outpoint measured within 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913145"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Home Access Health Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Home Access Health Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}